BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 32912960)

  • 1. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.
    Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N
    Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
    Hilton LK; Collinge BJ; Ben-Neriah S; Alduaij W; Shaalan H; Weng A; Cruz M; Slack GW; Farinha P; Miyata-Takata T; Boyle M; Meissner B; Cook JR; Ondrejka SL; Ott G; Rosenwald A; Campo E; Amador C; Greiner TC; Raess PW; Song JY; Inghirami GG; Jaffe ES; Weisenburger DD; Chan WC; Beiske K; Fu K; Delabie J; Pittaluga S; Iqbal J; Wright G; Sehn LH; Savage KJ; Mungall AJ; Feldman AL; Staudt LM; Steidl C; Rimsza LM; Morin RD; Scott DW
    Blood; 2024 May; ():. PubMed ID: 38701426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
    Quentmeier H; Drexler HG; Hauer V; MacLeod RA; Pommerenke C; Uphoff CC; Zaborski M; Berglund M; Enblad G; Amini RM
    PLoS One; 2016; 11(12):e0167599. PubMed ID: 27907212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass.
    Lin C; Kuma L; Shen L
    Pathology; 2024 Jun; 56(4):588-590. PubMed ID: 37940480
    [No Abstract]   [Full Text] [Related]  

  • 5. The genetic landscape of histologically transformed marginal zone lymphomas.
    Li A; Yi H; Deng S; Ruan M; Xu P; Huo Y; Lu H; Shen X; Ouyang B; Cai M; Xu H; Wang Z; Zhang L; Zhu L; Peng Q; Gu Y; Xie J; Wang Y; Dong L; Liu Z; Wang C
    Cancer; 2024 Apr; 130(8):1246-1256. PubMed ID: 37941429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
    Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma.
    Gopalakrishnan V; Roy U; Srivastava S; Kariya KM; Sharma S; Javedakar SM; Choudhary B; Raghavan SC
    Cell Mol Life Sci; 2024 Jan; 81(1):21. PubMed ID: 38196006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
    Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
    Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modification of primary human B cells to model high-grade lymphoma.
    Caeser R; Di Re M; Krupka JA; Gao J; Lara-Chica M; Dias JML; Cooke SL; Fenner R; Usheva Z; Runge HFP; Beer PA; Eldaly H; Pak HK; Park CS; Vassiliou GS; Huntly BJP; Mupo A; Bashford-Rogers RJM; Hodson DJ
    Nat Commun; 2019 Oct; 10(1):4543. PubMed ID: 31586074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial classic Hodgkin lymphoma and subsequent diffuse large B-cell lymphoma: separate entities with a continuum of BCL2 rearrangement.
    Gehris BT; Wang WJ; Mai B; Chen L; Wang W; Hu Z
    Pathology; 2024 Feb; 56(1):115-118. PubMed ID: 37573163
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications.
    Almasmoum HA
    J Appl Genet; 2024 Feb; 65(1):57-72. PubMed ID: 38001281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview.
    Argentiero A; Andriano A; Marziliano D; Desantis V
    Hematol Rep; 2024 Mar; 16(1):164-178. PubMed ID: 38534887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping Review.
    Manyau MCP; Zambuko B; Chatambudza M; Zhou DT; Manasa J
    Oncol Rev; 2024; 18():1375291. PubMed ID: 38707485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal presentation of a MYC/BCL6 double-hit lymphoma with 11q aberration in an older patient.
    Lefebvre C; Szymanski G
    Blood; 2023 Mar; 141(9):1093. PubMed ID: 36862431
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Tourneret A; Alame M; Rigau V; Bauchet L; Fabbro M; De Oliveira L; Cacheux V; Costes V; Lacheretz-Szablewski V
    J Clin Pathol; 2021 Oct; 74(10):650-656. PubMed ID: 32912960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
    J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 18. High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs.
    Marino FZ; Aquino G; Brunelli M; Scognamiglio G; Pedron S; Ronchi A; Cozzolino I; Sparano L; Botti G; Panico L; De Chiara A; Franco R;
    Virchows Arch; 2021 Sep; 479(3):565-573. PubMed ID: 33768318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.
    Jarosova M; Kriegova E; Schneiderova P; Fillerova R; Prochazka V; Mikesova M; Flodr P; Indrak K; Papajik T
    Pathol Oncol Res; 2016 Apr; 22(2):233-43. PubMed ID: 26319027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.